Tuesday 13 October 2026
Export CLX’s income statement to Excel — free account
The Clorox Company
CLX Consumer Defensive Household & Personal Products
The Clorox Company’s revenue for fiscal 2026 (year ended June 2026) was $6.7 billion, down 5.41% from fiscal 2025. In the quarter to June 2026, revenue fell 2.01%, EPS fell 50.4%, free cash flow grew 11.4% and total debt rose 60.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years; insiders bought in the last twelve months.
84.35
0.55
+0.66%
Follow CLX
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 159.95% | 536.17% | 967.95% | 437.02% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
4 | 6 | 5 | 5 | |
| 8.79% | 12.65% | 13.49% | 14.35% | ||
ROIC |
13.95% | 48.49% | 28.17% | 26.18% | |
Return on Tangible Assets |
104.26% | 103.42% | 120.22% | 111.10% | |
Average Days of Receivables |
42.96 | 36.23 | 36.24 | 37.90 | |
Free Cash Flow per Share |
3.33 | 3.13 | 6.40 | 5.19 | |
Free Cash Flow |
405.00 | 380.00 | 778.00 | 636.00 | |
Capital Expenditures |
(207.00) | (196.00) | (206.00) | (217.00) | |
| Other line items | |||||
Cash ROIC |
9.25% | 10.09% | 28.31% | 22.80% | |
Accounts Receivable Turnover |
8.34 | 10.66 | 10.61 | 10.43 | |
Accounts Payable Turnover |
2.26 | 2.17 | 2.21 | 2.22 | |
Inventory Turnover |
5.96 | 6.21 | 6.29 | 6.44 | |
Average Days of Payables |
150.67 | 142.21 | 189.37 | 186.62 | |
Days of Inventory on Hand |
73.17 | 56.54 | 58.83 | 55.88 | |
Tax Rate |
(0.24) | (0.22) | (0.22) | (0.20) | |
Research and Development Expense of Revenue |
1.73% | 1.72% | 1.72% | 1.74% | |
Selling, General and Administrative Expense of Revenue |
27.01% | 26.15% | 27.17% | 27.40% | |
Share Based Compensation of Revenue |
0.71% | 0.98% | 1.11% | 1.15% | |
Interest Coverage |
7.02 | 11.13 | 11.12 | 11.43 | |
Operating CF/Net income |
1.04 | 0.76 | 1.30 | 1.08 | |
Depreciation/Fixed assets |
0.16 | 0.18 | 0.18 | 0.18 | |
Capex/Depreciation |
(0.84) | (0.87) | (0.92) | (0.98) | |
Revenue per Share |
55.18 | 55.70 | 55.57 | 55.22 | |
Operating CF per Share |
5.03 | 4.75 | 8.09 | 6.96 | |
Capex per Share |
(1.70) | (1.61) | (1.69) | (1.77) | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 |
Columns are period end dates